Multimodal predictive factors of metastasis in lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma

Front Endocrinol (Lausanne). 2023 Jul 12:14:1187825. doi: 10.3389/fendo.2023.1187825. eCollection 2023.

Abstract

Objective: The lymph node posterior to the right recurrent laryngeal nerve (LN-prRLN) is a crucial component of the central lymph nodes (LNs). We aimed to evaluate multimodal predictive factors of LN-prRLN metastasis in patients with papillary thyroid carcinomas (PTCs), including the clinical data, pathologic data, and preoperative sonographic characteristics of PTCs.

Methods: A total of 403 diagnosed PTC patients who underwent unilateral, sub-total, or total thyroidectomy with central neck dissection were enrolled in this retrospective study. The clinical data, pathologic data, conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) characteristics of PTCs were collected and evaluated for predicting LN-prRLN metastasis.

Results: In this study, 96 PTC patients with LN-prRLN metastasis and 307 PTC patients without LN-prRLN metastasis were included. Univariate analysis demonstrated that PTC patients with LN-prRLN metastasis more often had younger age, larger size, multifocal cancers, A/T < 1, well-margins, microcalcification, petal-like calcification, internal vascularity, centripetal perfusion pattern and surrounding ring enhancement. Multivariate logistic regression analysis revealed that the CEUS centripetal perfusion pattern, central LN detected by ultrasound and LN-arRLN metastasis were independent characteristics for predicting LN-prRLN metastasis in PTC patients.

Conclusion: According to our research, it is essential for clinicians to thoroughly dissect central LNs, particularly LN-prRLNs.

Keywords: central cervical lymph node metastasis; contrast-enhanced ultrasound (CEUS); conventional Ultrasound; lymph nodes posterior to the right recurrent laryngeal nerve metastasis; papillary thyroid carcinomas (PTCs).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma* / pathology
  • Carcinoma, Papillary* / diagnostic imaging
  • Carcinoma, Papillary* / pathology
  • Carcinoma, Papillary* / surgery
  • Humans
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery
  • Lymphatic Metastasis / pathology
  • Recurrent Laryngeal Nerve / pathology
  • Retrospective Studies
  • Risk Factors
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Cancer, Papillary / surgery
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / surgery

Grants and funding

This project was funded by the National Natural Science Foundation of China (81974267), the Science and Technology Innovation Program of Hunan Province (2021RC3033), the Hunan Provincial Natural Science Foundation of China (2022JJ30827 and 2022JJ30806) and Natural Science Foundation of Hunan Provincial Health Commission (A202309026329).